Describe the recovery of breast cancer survivors.

Start with a brief summary about the trial. Then address the following questions. State your opinions with regard to the population that will be taking this drug.What are the ethical implications of the FDA practice of requiring a comparison with placebo in late stage development to test for efficacy versus denying placebo participants potential curative methods and not informing the participants they are taking a placebo and/or not getting the standard treatment?Should patients have the right to know they are in the placebo control group in this trial you selected? Why or why not? Does the FDA regulations require the participants be informed re: the placebo? Was that specific information readily available re: use of a placebo on the clinicaltrials.gov website?